[18F]GATT-39

N/A

Report date: 2025/11/21 17:16:40
NME

Base Information

Drug Name[18F]GATT-39
Drug Alias Name[18F]GATT-39
ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionGABA transporter 1 modulators
TargetsGABA transporter 1
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYale UniversityF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A